Article Type
Review
Published
This narrative review intends to list and discuss the glycaemic efficacy, key safety and weight loss outcomes related to the treatment of Type 2 diabetes with tirzepatide.
Review
This narrative review intends to list and discuss the glycaemic efficacy, key safety and weight loss outcomes related to the treatment of Type 2 diabetes with tirzepatide.
Corrigendum
The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10
Review
This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.
Review
This narrative review provides the most up-to-date information regarding existing and new pharmacotherapy for the management of chronic kidney disease amongst people with diabetes, specifically type 2 diabetes.
Editorial
The Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.